Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better project decisions… sooner.
Latest Quarterly Results
4th Quarter and Fiscal Year 2021 Results Press Release
4th Quarter and Fiscal Year 2021 Earnings Release Presentation
4th Quarter and Fiscal Year 2021 Webcast Info
4th Quarter and Fiscal Year 2021 Transcript
Upcoming Investor Presentation
There are no upcoming presentations currently scheduled